Across TCGA pan-cancer cohorts, PLSCR1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PLSCR1 data layer compared with 24 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher PLSCR1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated PLSCR1 expression acts as an unfavorable survival marker.

HNSC and SKCM are the cancer types where PLSCR1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	All	0.140	0.627	.011	24	view →
SKCM	DFS	Median	All	0.130	0.737	.003	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: PLSCR1 tumor-vs-normal RNA expression · all PLSCR1 data types